Compare Deckers Outdoor Corp (DECK) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Deckers Outdoor Corp vs Regeneron Pharmaceuticals Inc — how do they compare? Deckers Outdoor Corp trades at $106.98 (market cap $14.97B), while Regeneron Pharmaceuticals Inc trades at $655.5 (market cap $69.52B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 4.6× Deckers Outdoor Corp's market cap, and Regeneron Pharmaceuticals Inc pays a 0.57% dividend while Deckers Outdoor Corp pays none. Which is the better fit depends on your goals.
| DECK | REGN | |
|---|---|---|
Market Cap | $14.97B | $69.52B |
Sector | Consumer Cyclical | Health |
52-Week High | $123.91 | $812.27 |
52-Week Low | $79.54 | $542.52 |
Enterprise Value | $13.44B | $63.47B |
Dividend Yield | — | 0.57% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Deckers Outdoor Corp
Deckers Outdoor Corp designs and sells casual and performance footwear, apparel, and accessories. Primary brands include UGG, Teva, and Sanuk. The company distributes Most of its products through its wholesale business, but it also has a substantial direct-to-consumer business with its company-owned retail stores and websites. Most sales are in the United States, although the company also has retail stores and distributors throughout Europe, Asia, Canada, and Latin America. Deckers sources its products from independent manufacturers primarily in Asia.
Read more on DECK →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
